返回
Soft Tissue Sarcoma, Version 2.2018
DOI:10.6004/jnccn.2018.0025.png)
摘要
En 中文
Soft tissue sarcomas (STS) are rare solid tumors of mesenchymal cell origin that display a heterogenous mix of clinical and pathologic characteristics. STS can develop from fat, muscle, nerves, blood vessels, and other connective tissues. The evaluation and treatment of patients with STS requires a multidisciplinary team with demonstrated expertise in the management of these tumors. The complete NCCN Guidelines for STS provide recommendations for the diagnosis, evaluation, and treatment of extremity/superficial trunk/head and neck STS, as well as intra-abdominal/retroperitoneal STS, gastrointestinal stromal tumors, desmoid tumors, and rhabdomyosarcoma. This portion of the NCCN Guidelines discusses general principles for the diagnosis, staging, and treatment of STS of the extremities, superficial trunk, or head and neck; outlines treatment recommendations by disease stage; and reviews the evidence to support the guidelines recommendations.
Keyword:
POSITRON-EMISSION-TOMOGRAPHY
ISOLATED LIMB INFUSION
MODULATED RADIATION-THERAPY
NECROSIS-FACTOR-ALPHA
LONG-TERM OUTCOMES
HIGH-GRADE
NEOADJUVANT CHEMOTHERAPY
PROGNOSTIC-FACTORS
LOCAL RECURRENCE
TRUNK-WALL
AI总结
对已上传原文的论文进行重点信息的提取,主要内容包括:简要概述、研究摘要、背景介绍、关键亮点、图文解析、展望与总结。
期刊
J
IF:
16.4
论文数:
2.8K
被引数:
1.5W
机构
引用论文
暂无论文信息



